FDA delays Gardasil for older women

The FDA has decided to wait for more data from Merck before making a decision on whether or not to expand the indication of the HPV vaccine Gardasil for use in women ages 27 through 45, Merck announced today. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.